Medical hypotheses2021,Vol.15510.DOI:10.1016/j.mehy.2021.110656

Drug-repurposing against COVID-19 by targeting a key signaling pathway: An in silico study

Oh, Ki Kwang Adnan, Md. Ha Cho, Dong
Medical hypotheses2021,Vol.15510.DOI:10.1016/j.mehy.2021.110656

Drug-repurposing against COVID-19 by targeting a key signaling pathway: An in silico study

Oh, Ki Kwang 1Adnan, Md. 1Ha Cho, Dong1
扫码查看

作者信息

  • 1. Kangwon Natl Univ, Dept Biohlth Convergence, Coll Biomed Sci, Chunchon 24341, South Korea
  • 折叠

Abstract

Currently, a plethora of information has been accumulated concerning COVID-19, including the transmission pathway of SARs-CoV-2. Thus, we retrieved targets associated with the development of COVID-19 via PubChem. A total of 517 targets were identified, and signaling pathways responded after infection of SARs-CoV-2 in humans constructed a bubble chart using RPackage. The bubble chart result suggested that the key signaling pathway against COVID-19 was the estrogen signaling pathway associated with AKT1, HSP90AB1, BCL2 targets. The three targets have the strongest affinity with three ligands-Akti-1/2, HSP990, S55746, respectively. In conclusion, this work provides three key elements to alleviate COVID-19 symptoms might be anti-inflammatory effects on SARsCoV-2-infected lung cells.

Key words

COVID-19/Estrogen signaling pathway/AKT1-HSP90AB1-BCL2/Akti-1/2-HSP990-S55746/Anti-inflammatory effects

引用本文复制引用

出版年

2021
Medical hypotheses

Medical hypotheses

SCI
ISSN:0306-9877
被引量5
参考文献量24
段落导航相关论文